William Weldon is Chairman and Chief Executive Officer of Johnson & Johnson and is the sixth Chairman in Johnson & Johnson's over one-hundred year history.
Weldon joined J&J as a sales representative for the McNeil Pharameutical division in 1971 and eventually became the head of J&J's Ethicon Endo-Surgery business in 1992. He became the head of J&J's pharmaceutical operations in 1998 and then became J&J's CEO in 2002. As CEO, Weldon engineered some of the largest acquisitions in J&J's history including the purchase of ALZA and Pfizer's consumer-health product line.
William Weldon received a BA in Biology from Quinnipiac University.
The way our business is set up is that we have three businesses. The largest portion of our business is in pharmaceuticals and it's about 40%, next is our medical device and diagnostics and then our consumer business. Most people think of J&J as a consumer company and think of it as Band-Aid, baby...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
